Renal Denervation Market By Product Type (Symplicity, Enlightn, Vessix, Paradise, Iberis, Others), By Technology (Radiofrequency, Ultrasound, Micro-Infusion), By End User (Hospitals, Specialty Clinics, Others): Global Opportunity Analysis and Industry Forecast, 2020-2030
The global renal denervation market size was valued at $156,327.4 thousand in 2020, and is projected to reach $4,555,983.0thousandby 2030, registering a CAGR of 40.7% from 2021 to 2030.Renal denervation is a catheter-based minimally invasive therapy used to treat hypertension in patients. Renal denervation is usually used when other treatments have failed to relieve the patient's symptoms. The renal artery wall nerves are ablated with ultrasound or radio frequency pulses in this operation. Hence, ultrasound renal denervation helps in reducing blood pressure in patient with hypertension.
The renal denervation market has grown owning to excessive alcohol consumption, lack of physical exercises &activities, smoking, and fast-food consumption all contribute to an increased risk of hypertension. Further, it causes various disorders, such as heart attacks, stroke, pulmonary arterial hypertension, and also cause high blood pressure. As a result, during the forecast period, such factor is expected to create growth opportunity for renal denervation system for treating hypertension and other diseases.
Furthermore, there is large number of renal denervation devices, which are manufactured by major key players in the market to treat hypertension and other diseases. For instance, in November 2021, Medtronic Plc, manufacturer of medical devices and technologies announced Spyral Affirm study evaluating safety, durability of Symplicity renal denervation system to control hypertension and other disorder such as diabetes, chronic kidney disease, and isolated systolic hypertension.
The market is segmented on the basis of product, technology, and geography. On the basis of product, the market is divided into symplicity, enligHTN, vessix, paradise, and iberis. On the basis of technology, the market is divided into radiofrequency, ultrasound, and micro-infusion. On the basis of end user, the market is divided into hospitals, specialty clinics, and others. Region wise, the market analysis is conducted across North America (the U.S., Canada, and Mexico), Europe (the UK, France, Germany, Italy, and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, and Rest of Asia-Pacific), and LAMEA (Latin America, the Middle East, and Africa).
COMPETITION ANALYSIS
The key players that operate in the global renal denervation are Ablative Solutions, Inc., Abbott Laboratories, Johnson & Johnson, Cardiosonic Ltd, Boston Scientific Corporation, Medtronic plc, Mercator MedSystems, Inc., ReCor Medical, Inc., Renal Dynamics Limited, and Terumo Corporation.
Key Benefits For Stakeholders
The report provides an extensive analysis of the current and emerging renal denervation market trends and dynamics.
In-depth renal denervation market analysis is conducted by constructing market estimations for key market segments between 2021 and 2030.
Extensive analysis of the renal denervation market growth is conducted by following key product positioning and monitoring of top competitors within the market framework.
The report includes renal denervation market opportunity.
The global renal denervation market forecast analysis from 2021 to 2030 is included in the report.
The key players within renal denervation market are profiled in this report and their strategies are analyzed thoroughly, which help understand the competitive outlook of the renal denervation industry.
KEY BENEFITS FOR STAKEHOLDERS
The report provides an extensive analysis of the current and emerging renal denervation market trends and dynamics.
In-depth renal denervation market analysis is conducted by constructing market estimations for key market segments between 2021 and 2030.
Extensive analysis of the renal denervation market is conducted by following key product positioning and monitoring of top competitors within the market framework.
A comprehensive analysis of all the regions is provided to determine the prevailing opportunities.
The global renal denervation market forecast analysis from 2021 to 2030 is included in the report.
The key players within renal denervation market are profiled in this report and their strategies are analyzed thoroughly, which help understand the competitive outlook of the renal denervation industry.
Key Market Segments
By BY PRODUCT TYPE
Symplicity
Enlightn
Vessix
Paradise
Iberis
Others
By BY TECHNOLOGY
Radiofrequency
Ultrasound
Micro-Infusion
By BY END USER
Hospitals
Specialty Clinics
Others
By BY REGION
Asia-Pacific
China
India
Japan
Australia
Rest of Asia-Pacific
Europe
Germany
France
UK
Italy
Rest of Europe
LAMEA
Latin America
Middle East
Africa
North America
U.S.
Canada
Mexico
Key Market Players
Ablative Solutions, Inc
Abbott Laboratories
Johnson & Johnson
Cardiosonic Ltd
Boston Scientific Corporation
Medtronic plc
Mercator MedSystems, Inc
ReCor Medical, Inc
Renal Dynamics Limited
terumo corporation
- CHAPTER 1:INTRODUCTION
- 1.1.Report description
- 1.2.Key market segments
- 1.3.Key benefits to the stakeholders
- 1.4.Research Methodology
- 1.4.1.Secondary research
- 1.4.2.Primary research
- 1.4.3.Analyst tools and models
- CHAPTER 2:EXECUTIVE SUMMARY
- 2.1.Key findings of the study
- 2.2.CXO Perspective
- CHAPTER 3:MARKET OVERVIEW
- 3.1.Market definition and scope
- 3.2.Key findings
- 3.2.1.Top investment pockets
- 3.3.Porter’s five forces analysis
- 3.4.Top player positioning
- 3.5.Market dynamics
- 3.5.1.Drivers
- 3.5.2.Restraints
- 3.5.3.Opportunities
- 3.6.COVID-19 Impact Analysis on the market
- CHAPTER 4: RENAL DENERVATION MARKET, BY PRODUCT TYPE
- 4.1 Overview
- 4.1.1 Market size and forecast
- 4.2 Symplicity
- 4.2.1 Key market trends, growth factors and opportunities
- 4.2.2 Market size and forecast, by region
- 4.2.3 Market analysis by country
- 4.3 Enlightn
- 4.3.1 Key market trends, growth factors and opportunities
- 4.3.2 Market size and forecast, by region
- 4.3.3 Market analysis by country
- 4.4 Vessix
- 4.4.1 Key market trends, growth factors and opportunities
- 4.4.2 Market size and forecast, by region
- 4.4.3 Market analysis by country
- 4.5 Paradise
- 4.5.1 Key market trends, growth factors and opportunities
- 4.5.2 Market size and forecast, by region
- 4.5.3 Market analysis by country
- 4.6 Iberis
- 4.6.1 Key market trends, growth factors and opportunities
- 4.6.2 Market size and forecast, by region
- 4.6.3 Market analysis by country
- 4.7 Others
- 4.7.1 Key market trends, growth factors and opportunities
- 4.7.2 Market size and forecast, by region
- 4.7.3 Market analysis by country
- CHAPTER 5: RENAL DENERVATION MARKET, BY TECHNOLOGY
- 5.1 Overview
- 5.1.1 Market size and forecast
- 5.2 Radiofrequency
- 5.2.1 Key market trends, growth factors and opportunities
- 5.2.2 Market size and forecast, by region
- 5.2.3 Market analysis by country
- 5.3 Ultrasound
- 5.3.1 Key market trends, growth factors and opportunities
- 5.3.2 Market size and forecast, by region
- 5.3.3 Market analysis by country
- 5.4 Micro-Infusion
- 5.4.1 Key market trends, growth factors and opportunities
- 5.4.2 Market size and forecast, by region
- 5.4.3 Market analysis by country
- CHAPTER 6: RENAL DENERVATION MARKET, BY END USER
- 6.1 Overview
- 6.1.1 Market size and forecast
- 6.2 Hospitals
- 6.2.1 Key market trends, growth factors and opportunities
- 6.2.2 Market size and forecast, by region
- 6.2.3 Market analysis by country
- 6.3 Specialty Clinics
- 6.3.1 Key market trends, growth factors and opportunities
- 6.3.2 Market size and forecast, by region
- 6.3.3 Market analysis by country
- 6.4 Others
- 6.4.1 Key market trends, growth factors and opportunities
- 6.4.2 Market size and forecast, by region
- 6.4.3 Market analysis by country
- CHAPTER 7: RENAL DENERVATION MARKET, BY REGION
- 7.1 Overview
- 7.1.1 Market size and forecast
- 7.2 Asia-Pacific
- 7.2.1 Key trends and opportunities
- 7.2.2 Asia-Pacific Market size and forecast, by Product Type
- 7.2.3 Asia-Pacific Market size and forecast, by Technology
- 7.2.4 Asia-Pacific Market size and forecast, by End User
- 7.2.5 Asia-Pacific Market size and forecast, by country
- 7.2.5.1 China
- 7.2.5.1.1 Market size and forecast, by Product Type
- 7.2.5.1.2 Market size and forecast, by Technology
- 7.2.5.1.3 Market size and forecast, by End User
- 7.2.5.2 India
- 7.2.5.2.1 Market size and forecast, by Product Type
- 7.2.5.2.2 Market size and forecast, by Technology
- 7.2.5.2.3 Market size and forecast, by End User
- 7.2.5.3 Japan
- 7.2.5.3.1 Market size and forecast, by Product Type
- 7.2.5.3.2 Market size and forecast, by Technology
- 7.2.5.3.3 Market size and forecast, by End User
- 7.2.5.4 Australia
- 7.2.5.4.1 Market size and forecast, by Product Type
- 7.2.5.4.2 Market size and forecast, by Technology
- 7.2.5.4.3 Market size and forecast, by End User
- 7.2.5.5 Rest of Asia-Pacific
- 7.2.5.5.1 Market size and forecast, by Product Type
- 7.2.5.5.2 Market size and forecast, by Technology
- 7.2.5.5.3 Market size and forecast, by End User
- 7.3 Europe
- 7.3.1 Key trends and opportunities
- 7.3.2 Europe Market size and forecast, by Product Type
- 7.3.3 Europe Market size and forecast, by Technology
- 7.3.4 Europe Market size and forecast, by End User
- 7.3.5 Europe Market size and forecast, by country
- 7.3.5.1 Germany
- 7.3.5.1.1 Market size and forecast, by Product Type
- 7.3.5.1.2 Market size and forecast, by Technology
- 7.3.5.1.3 Market size and forecast, by End User
- 7.3.5.2 France
- 7.3.5.2.1 Market size and forecast, by Product Type
- 7.3.5.2.2 Market size and forecast, by Technology
- 7.3.5.2.3 Market size and forecast, by End User
- 7.3.5.3 U.K.
- 7.3.5.3.1 Market size and forecast, by Product Type
- 7.3.5.3.2 Market size and forecast, by Technology
- 7.3.5.3.3 Market size and forecast, by End User
- 7.3.5.4 Italy
- 7.3.5.4.1 Market size and forecast, by Product Type
- 7.3.5.4.2 Market size and forecast, by Technology
- 7.3.5.4.3 Market size and forecast, by End User
- 7.3.5.5 Rest of Europe
- 7.3.5.5.1 Market size and forecast, by Product Type
- 7.3.5.5.2 Market size and forecast, by Technology
- 7.3.5.5.3 Market size and forecast, by End User
- 7.4 LAMEA
- 7.4.1 Key trends and opportunities
- 7.4.2 LAMEA Market size and forecast, by Product Type
- 7.4.3 LAMEA Market size and forecast, by Technology
- 7.4.4 LAMEA Market size and forecast, by End User
- 7.4.5 LAMEA Market size and forecast, by country
- 7.4.5.1 Latin America
- 7.4.5.1.1 Market size and forecast, by Product Type
- 7.4.5.1.2 Market size and forecast, by Technology
- 7.4.5.1.3 Market size and forecast, by End User
- 7.4.5.2 Middle East
- 7.4.5.2.1 Market size and forecast, by Product Type
- 7.4.5.2.2 Market size and forecast, by Technology
- 7.4.5.2.3 Market size and forecast, by End User
- 7.4.5.3 Africa
- 7.4.5.3.1 Market size and forecast, by Product Type
- 7.4.5.3.2 Market size and forecast, by Technology
- 7.4.5.3.3 Market size and forecast, by End User
- 7.5 North America
- 7.5.1 Key trends and opportunities
- 7.5.2 North America Market size and forecast, by Product Type
- 7.5.3 North America Market size and forecast, by Technology
- 7.5.4 North America Market size and forecast, by End User
- 7.5.5 North America Market size and forecast, by country
- 7.5.5.1 U.S.
- 7.5.5.1.1 Market size and forecast, by Product Type
- 7.5.5.1.2 Market size and forecast, by Technology
- 7.5.5.1.3 Market size and forecast, by End User
- 7.5.5.2 Canada
- 7.5.5.2.1 Market size and forecast, by Product Type
- 7.5.5.2.2 Market size and forecast, by Technology
- 7.5.5.2.3 Market size and forecast, by End User
- 7.5.5.3 Mexico
- 7.5.5.3.1 Market size and forecast, by Product Type
- 7.5.5.3.2 Market size and forecast, by Technology
- 7.5.5.3.3 Market size and forecast, by End User
- CHAPTER 8: COMPANY LANDSCAPE
- 8.1. Introduction
- 8.2. Top winning strategies
- 8.3. Product Mapping of Top 10 Player
- 8.4. Competitive Dashboard
- 8.5. Competitive Heatmap
- 8.6. Key developments
- CHAPTER 9: COMPANY PROFILES
- 9.1 Ablative Solutions, Inc
- 9.1.1 Company overview
- 9.1.2 Company snapshot
- 9.1.3 Operating business segments
- 9.1.4 Product portfolio
- 9.1.5 Business performance
- 9.1.6 Key strategic moves and developments
- 9.2 Abbott Laboratories
- 9.2.1 Company overview
- 9.2.2 Company snapshot
- 9.2.3 Operating business segments
- 9.2.4 Product portfolio
- 9.2.5 Business performance
- 9.2.6 Key strategic moves and developments
- 9.3 Johnson & Johnson
- 9.3.1 Company overview
- 9.3.2 Company snapshot
- 9.3.3 Operating business segments
- 9.3.4 Product portfolio
- 9.3.5 Business performance
- 9.3.6 Key strategic moves and developments
- 9.4 Cardiosonic Ltd
- 9.4.1 Company overview
- 9.4.2 Company snapshot
- 9.4.3 Operating business segments
- 9.4.4 Product portfolio
- 9.4.5 Business performance
- 9.4.6 Key strategic moves and developments
- 9.5 Boston Scientific Corporation
- 9.5.1 Company overview
- 9.5.2 Company snapshot
- 9.5.3 Operating business segments
- 9.5.4 Product portfolio
- 9.5.5 Business performance
- 9.5.6 Key strategic moves and developments
- 9.6 Medtronic plc
- 9.6.1 Company overview
- 9.6.2 Company snapshot
- 9.6.3 Operating business segments
- 9.6.4 Product portfolio
- 9.6.5 Business performance
- 9.6.6 Key strategic moves and developments
- 9.7 Mercator MedSystems, Inc
- 9.7.1 Company overview
- 9.7.2 Company snapshot
- 9.7.3 Operating business segments
- 9.7.4 Product portfolio
- 9.7.5 Business performance
- 9.7.6 Key strategic moves and developments
- 9.8 ReCor Medical, Inc
- 9.8.1 Company overview
- 9.8.2 Company snapshot
- 9.8.3 Operating business segments
- 9.8.4 Product portfolio
- 9.8.5 Business performance
- 9.8.6 Key strategic moves and developments
- 9.9 Renal Dynamics Limited
- 9.9.1 Company overview
- 9.9.2 Company snapshot
- 9.9.3 Operating business segments
- 9.9.4 Product portfolio
- 9.9.5 Business performance
- 9.9.6 Key strategic moves and developments
- 9.10 terumo corporation
- 9.10.1 Company overview
- 9.10.2 Company snapshot
- 9.10.3 Operating business segments
- 9.10.4 Product portfolio
- 9.10.5 Business performance
- 9.10.6 Key strategic moves and developments
- LIST OF TABLES
- TABLE 1. GLOBAL RENAL DENERVATION MARKET, BY PRODUCT TYPE, 2020-2030,($THOUSAND)
- TABLE 2. RENAL DENERVATION MARKET REVENUE, FOR SYMPLICITY, BY REGION , 2020-2030,($THOUSAND)
- TABLE 3. RENAL DENERVATION MARKET SYMPLICITY BY COUNTRY, 2020-2030,($THOUSAND)
- TABLE 4. RENAL DENERVATION MARKET REVENUE, FOR ENLIGHTN, BY REGION , 2020-2030,($THOUSAND)
- TABLE 5. RENAL DENERVATION MARKET ENLIGHTN BY COUNTRY, 2020-2030,($THOUSAND)
- TABLE 6. RENAL DENERVATION MARKET REVENUE, FOR VESSIX, BY REGION , 2020-2030,($THOUSAND)
- TABLE 7. RENAL DENERVATION MARKET VESSIX BY COUNTRY, 2020-2030,($THOUSAND)
- TABLE 8. RENAL DENERVATION MARKET REVENUE, FOR PARADISE, BY REGION , 2020-2030,($THOUSAND)
- TABLE 9. RENAL DENERVATION MARKET PARADISE BY COUNTRY, 2020-2030,($THOUSAND)
- TABLE 10. RENAL DENERVATION MARKET REVENUE, FOR IBERIS, BY REGION , 2020-2030,($THOUSAND)
- TABLE 11. RENAL DENERVATION MARKET IBERIS BY COUNTRY, 2020-2030,($THOUSAND)
- TABLE 12. RENAL DENERVATION MARKET REVENUE, FOR OTHERS, BY REGION , 2020-2030,($THOUSAND)
- TABLE 13. RENAL DENERVATION MARKET OTHERS BY COUNTRY, 2020-2030,($THOUSAND)
- TABLE 14. GLOBAL RENAL DENERVATION MARKET, BY TECHNOLOGY, 2020-2030,($THOUSAND)
- TABLE 15. RENAL DENERVATION MARKET REVENUE, FOR RADIOFREQUENCY, BY REGION , 2020-2030,($THOUSAND)
- TABLE 16. RENAL DENERVATION MARKET RADIOFREQUENCY BY COUNTRY, 2020-2030,($THOUSAND)
- TABLE 17. RENAL DENERVATION MARKET REVENUE, FOR ULTRASOUND, BY REGION , 2020-2030,($THOUSAND)
- TABLE 18. RENAL DENERVATION MARKET ULTRASOUND BY COUNTRY, 2020-2030,($THOUSAND)
- TABLE 19. RENAL DENERVATION MARKET REVENUE, FOR MICRO-INFUSION, BY REGION , 2020-2030,($THOUSAND)
- TABLE 20. RENAL DENERVATION MARKET MICRO-INFUSION BY COUNTRY, 2020-2030,($THOUSAND)
- TABLE 21. GLOBAL RENAL DENERVATION MARKET, BY END USER, 2020-2030,($THOUSAND)
- TABLE 22. RENAL DENERVATION MARKET REVENUE, FOR HOSPITALS, BY REGION , 2020-2030,($THOUSAND)
- TABLE 23. RENAL DENERVATION MARKET HOSPITALS BY COUNTRY, 2020-2030,($THOUSAND)
- TABLE 24. RENAL DENERVATION MARKET REVENUE, FOR SPECIALTY CLINICS, BY REGION , 2020-2030,($THOUSAND)
- TABLE 25. RENAL DENERVATION MARKET SPECIALTY CLINICS BY COUNTRY, 2020-2030,($THOUSAND)
- TABLE 26. RENAL DENERVATION MARKET REVENUE, FOR OTHERS, BY REGION , 2020-2030,($THOUSAND)
- TABLE 27. RENAL DENERVATION MARKET OTHERS BY COUNTRY, 2020-2030,($THOUSAND)
- TABLE 28. RENAL DENERVATION MARKET, BY REGION, 2020-2030,($THOUSAND)
- TABLE 29. ASIA-PACIFIC RENAL DENERVATION MARKET, BY PRODUCT TYPE, 2020-2030,($THOUSAND)
- TABLE 30. ASIA-PACIFIC RENAL DENERVATION MARKET, BY TECHNOLOGY, 2020-2030,($THOUSAND)
- TABLE 31. ASIA-PACIFIC RENAL DENERVATION MARKET, BY END USER, 2020-2030,($THOUSAND)
- TABLE 32. ASIA-PACIFIC RENAL DENERVATION MARKET, BY COUNTRY, 2020-2030,($THOUSAND)
- TABLE 33. CHINA RENAL DENERVATION MARKET BY PRODUCT TYPE 2020-2030,($THOUSAND)
- TABLE 34. CHINA RENAL DENERVATION MARKET BY TECHNOLOGY 2020-2030,($THOUSAND)
- TABLE 35. CHINA RENAL DENERVATION MARKET BY END USER 2020-2030,($THOUSAND)
- TABLE 36. INDIA RENAL DENERVATION MARKET BY PRODUCT TYPE 2020-2030,($THOUSAND)
- TABLE 37. INDIA RENAL DENERVATION MARKET BY TECHNOLOGY 2020-2030,($THOUSAND)
- TABLE 38. INDIA RENAL DENERVATION MARKET BY END USER 2020-2030,($THOUSAND)
- TABLE 39. JAPAN RENAL DENERVATION MARKET BY PRODUCT TYPE 2020-2030,($THOUSAND)
- TABLE 40. JAPAN RENAL DENERVATION MARKET BY TECHNOLOGY 2020-2030,($THOUSAND)
- TABLE 41. JAPAN RENAL DENERVATION MARKET BY END USER 2020-2030,($THOUSAND)
- TABLE 42. AUSTRALIA RENAL DENERVATION MARKET BY PRODUCT TYPE 2020-2030,($THOUSAND)
- TABLE 43. AUSTRALIA RENAL DENERVATION MARKET BY TECHNOLOGY 2020-2030,($THOUSAND)
- TABLE 44. AUSTRALIA RENAL DENERVATION MARKET BY END USER 2020-2030,($THOUSAND)
- TABLE 45. REST OF ASIA-PACIFIC RENAL DENERVATION MARKET BY PRODUCT TYPE 2020-2030,($THOUSAND)
- TABLE 46. REST OF ASIA-PACIFIC RENAL DENERVATION MARKET BY TECHNOLOGY 2020-2030,($THOUSAND)
- TABLE 47. REST OF ASIA-PACIFIC RENAL DENERVATION MARKET BY END USER 2020-2030,($THOUSAND)
- TABLE 48. EUROPE RENAL DENERVATION MARKET, BY PRODUCT TYPE, 2020-2030,($THOUSAND)
- TABLE 49. EUROPE RENAL DENERVATION MARKET, BY TECHNOLOGY, 2020-2030,($THOUSAND)
- TABLE 50. EUROPE RENAL DENERVATION MARKET, BY END USER, 2020-2030,($THOUSAND)
- TABLE 51. EUROPE RENAL DENERVATION MARKET, BY COUNTRY, 2020-2030,($THOUSAND)
- TABLE 52. GERMANY RENAL DENERVATION MARKET BY PRODUCT TYPE 2020-2030,($THOUSAND)
- TABLE 53. GERMANY RENAL DENERVATION MARKET BY TECHNOLOGY 2020-2030,($THOUSAND)
- TABLE 54. GERMANY RENAL DENERVATION MARKET BY END USER 2020-2030,($THOUSAND)
- TABLE 55. FRANCE RENAL DENERVATION MARKET BY PRODUCT TYPE 2020-2030,($THOUSAND)
- TABLE 56. FRANCE RENAL DENERVATION MARKET BY TECHNOLOGY 2020-2030,($THOUSAND)
- TABLE 57. FRANCE RENAL DENERVATION MARKET BY END USER 2020-2030,($THOUSAND)
- TABLE 58. U.K. RENAL DENERVATION MARKET BY PRODUCT TYPE 2020-2030,($THOUSAND)
- TABLE 59. U.K. RENAL DENERVATION MARKET BY TECHNOLOGY 2020-2030,($THOUSAND)
- TABLE 60. U.K. RENAL DENERVATION MARKET BY END USER 2020-2030,($THOUSAND)
- TABLE 61. ITALY RENAL DENERVATION MARKET BY PRODUCT TYPE 2020-2030,($THOUSAND)
- TABLE 62. ITALY RENAL DENERVATION MARKET BY TECHNOLOGY 2020-2030,($THOUSAND)
- TABLE 63. ITALY RENAL DENERVATION MARKET BY END USER 2020-2030,($THOUSAND)
- TABLE 64. REST OF EUROPE RENAL DENERVATION MARKET BY PRODUCT TYPE 2020-2030,($THOUSAND)
- TABLE 65. REST OF EUROPE RENAL DENERVATION MARKET BY TECHNOLOGY 2020-2030,($THOUSAND)
- TABLE 66. REST OF EUROPE RENAL DENERVATION MARKET BY END USER 2020-2030,($THOUSAND)
- TABLE 67. LAMEA RENAL DENERVATION MARKET, BY PRODUCT TYPE, 2020-2030,($THOUSAND)
- TABLE 68. LAMEA RENAL DENERVATION MARKET, BY TECHNOLOGY, 2020-2030,($THOUSAND)
- TABLE 69. LAMEA RENAL DENERVATION MARKET, BY END USER, 2020-2030,($THOUSAND)
- TABLE 70. LAMEA RENAL DENERVATION MARKET, BY COUNTRY, 2020-2030,($THOUSAND)
- TABLE 71. LATIN AMERICA RENAL DENERVATION MARKET BY PRODUCT TYPE 2020-2030,($THOUSAND)
- TABLE 72. LATIN AMERICA RENAL DENERVATION MARKET BY TECHNOLOGY 2020-2030,($THOUSAND)
- TABLE 73. LATIN AMERICA RENAL DENERVATION MARKET BY END USER 2020-2030,($THOUSAND)
- TABLE 74. MIDDLE EAST RENAL DENERVATION MARKET BY PRODUCT TYPE 2020-2030,($THOUSAND)
- TABLE 75. MIDDLE EAST RENAL DENERVATION MARKET BY TECHNOLOGY 2020-2030,($THOUSAND)
- TABLE 76. MIDDLE EAST RENAL DENERVATION MARKET BY END USER 2020-2030,($THOUSAND)
- TABLE 77. AFRICA RENAL DENERVATION MARKET BY PRODUCT TYPE 2020-2030,($THOUSAND)
- TABLE 78. AFRICA RENAL DENERVATION MARKET BY TECHNOLOGY 2020-2030,($THOUSAND)
- TABLE 79. AFRICA RENAL DENERVATION MARKET BY END USER 2020-2030,($THOUSAND)
- TABLE 80. NORTH AMERICA RENAL DENERVATION MARKET, BY PRODUCT TYPE, 2020-2030,($THOUSAND)
- TABLE 81. NORTH AMERICA RENAL DENERVATION MARKET, BY TECHNOLOGY, 2020-2030,($THOUSAND)
- TABLE 82. NORTH AMERICA RENAL DENERVATION MARKET, BY END USER, 2020-2030,($THOUSAND)
- TABLE 83. NORTH AMERICA RENAL DENERVATION MARKET, BY COUNTRY, 2020-2030,($THOUSAND)
- TABLE 84. U.S. RENAL DENERVATION MARKET BY PRODUCT TYPE 2020-2030,($THOUSAND)
- TABLE 85. U.S. RENAL DENERVATION MARKET BY TECHNOLOGY 2020-2030,($THOUSAND)
- TABLE 86. U.S. RENAL DENERVATION MARKET BY END USER 2020-2030,($THOUSAND)
- TABLE 87. CANADA RENAL DENERVATION MARKET BY PRODUCT TYPE 2020-2030,($THOUSAND)
- TABLE 88. CANADA RENAL DENERVATION MARKET BY TECHNOLOGY 2020-2030,($THOUSAND)
- TABLE 89. CANADA RENAL DENERVATION MARKET BY END USER 2020-2030,($THOUSAND)
- TABLE 90. MEXICO RENAL DENERVATION MARKET BY PRODUCT TYPE 2020-2030,($THOUSAND)
- TABLE 91. MEXICO RENAL DENERVATION MARKET BY TECHNOLOGY 2020-2030,($THOUSAND)
- TABLE 92. MEXICO RENAL DENERVATION MARKET BY END USER 2020-2030,($THOUSAND)
- TABLE 93.ABLATIVE SOLUTIONS, INC: COMPANY SNAPSHOT
- TABLE 94.ABLATIVE SOLUTIONS, INC: OPERATING SEGMENTS
- TABLE 95.ABLATIVE SOLUTIONS, INC: PRODUCT PORTFOLIO
- TABLE 96.ABLATIVE SOLUTIONS, INC: NET SALES,
- TABLE 97.ABLATIVE SOLUTIONS, INC: KEY STRATERGIES
- TABLE 98.ABBOTT LABORATORIES: COMPANY SNAPSHOT
- TABLE 99.ABBOTT LABORATORIES: OPERATING SEGMENTS
- TABLE 100.ABBOTT LABORATORIES: PRODUCT PORTFOLIO
- TABLE 101.ABBOTT LABORATORIES: NET SALES,
- TABLE 102.ABBOTT LABORATORIES: KEY STRATERGIES
- TABLE 103.JOHNSON & JOHNSON: COMPANY SNAPSHOT
- TABLE 104.JOHNSON & JOHNSON: OPERATING SEGMENTS
- TABLE 105.JOHNSON & JOHNSON: PRODUCT PORTFOLIO
- TABLE 106.JOHNSON & JOHNSON: NET SALES,
- TABLE 107.JOHNSON & JOHNSON: KEY STRATERGIES
- TABLE 108.CARDIOSONIC LTD: COMPANY SNAPSHOT
- TABLE 109.CARDIOSONIC LTD: OPERATING SEGMENTS
- TABLE 110.CARDIOSONIC LTD: PRODUCT PORTFOLIO
- TABLE 111.CARDIOSONIC LTD: NET SALES,
- TABLE 112.CARDIOSONIC LTD: KEY STRATERGIES
- TABLE 113.BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
- TABLE 114.BOSTON SCIENTIFIC CORPORATION: OPERATING SEGMENTS
- TABLE 115.BOSTON SCIENTIFIC CORPORATION: PRODUCT PORTFOLIO
- TABLE 116.BOSTON SCIENTIFIC CORPORATION: NET SALES,
- TABLE 117.BOSTON SCIENTIFIC CORPORATION: KEY STRATERGIES
- TABLE 118.MEDTRONIC PLC: COMPANY SNAPSHOT
- TABLE 119.MEDTRONIC PLC: OPERATING SEGMENTS
- TABLE 120.MEDTRONIC PLC: PRODUCT PORTFOLIO
- TABLE 121.MEDTRONIC PLC: NET SALES,
- TABLE 122.MEDTRONIC PLC: KEY STRATERGIES
- TABLE 123.MERCATOR MEDSYSTEMS, INC: COMPANY SNAPSHOT
- TABLE 124.MERCATOR MEDSYSTEMS, INC: OPERATING SEGMENTS
- TABLE 125.MERCATOR MEDSYSTEMS, INC: PRODUCT PORTFOLIO
- TABLE 126.MERCATOR MEDSYSTEMS, INC: NET SALES,
- TABLE 127.MERCATOR MEDSYSTEMS, INC: KEY STRATERGIES
- TABLE 128.RECOR MEDICAL, INC: COMPANY SNAPSHOT
- TABLE 129.RECOR MEDICAL, INC: OPERATING SEGMENTS
- TABLE 130.RECOR MEDICAL, INC: PRODUCT PORTFOLIO
- TABLE 131.RECOR MEDICAL, INC: NET SALES,
- TABLE 132.RECOR MEDICAL, INC: KEY STRATERGIES
- TABLE 133.RENAL DYNAMICS LIMITED: COMPANY SNAPSHOT
- TABLE 134.RENAL DYNAMICS LIMITED: OPERATING SEGMENTS
- TABLE 135.RENAL DYNAMICS LIMITED: PRODUCT PORTFOLIO
- TABLE 136.RENAL DYNAMICS LIMITED: NET SALES,
- TABLE 137.RENAL DYNAMICS LIMITED: KEY STRATERGIES
- TABLE 138.TERUMO CORPORATION: COMPANY SNAPSHOT
- TABLE 139.TERUMO CORPORATION: OPERATING SEGMENTS
- TABLE 140.TERUMO CORPORATION: PRODUCT PORTFOLIO
- TABLE 141.TERUMO CORPORATION: NET SALES,
- TABLE 142.TERUMO CORPORATION: KEY STRATERGIES
- LIST OF FIGURES
- FIGURE 1.RENAL DENERVATION MARKET SEGMENTATION
- FIGURE 2.RENAL DENERVATION MARKET,2020-2030
- FIGURE 3.RENAL DENERVATION MARKET,2020-2030
- FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
- FIGURE 5.PORTER FIVE-1
- FIGURE 6.PORTER FIVE-2
- FIGURE 7.PORTER FIVE-3
- FIGURE 8.PORTER FIVE-4
- FIGURE 9.PORTER FIVE-5
- FIGURE 10.TOP PLAYER POSITIONING
- FIGURE 11.RENAL DENERVATION MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
- FIGURE 11.RENAL DENERVATION MARKET,BY PRODUCT TYPE,2020(%)
- FIGURE 12.COMPARATIVE SHARE ANALYSIS OF SYMPLICITY RENAL DENERVATION MARKET,2020-2030(%)
- FIGURE 13.COMPARATIVE SHARE ANALYSIS OF ENLIGHTN RENAL DENERVATION MARKET,2020-2030(%)
- FIGURE 14.COMPARATIVE SHARE ANALYSIS OF VESSIX RENAL DENERVATION MARKET,2020-2030(%)
- FIGURE 15.COMPARATIVE SHARE ANALYSIS OF PARADISE RENAL DENERVATION MARKET,2020-2030(%)
- FIGURE 16.COMPARATIVE SHARE ANALYSIS OF IBERIS RENAL DENERVATION MARKET,2020-2030(%)
- FIGURE 17.COMPARATIVE SHARE ANALYSIS OF OTHERS RENAL DENERVATION MARKET,2020-2030(%)
- FIGURE 18.RENAL DENERVATION MARKET,BY TECHNOLOGY,2020(%)
- FIGURE 19.COMPARATIVE SHARE ANALYSIS OF RADIOFREQUENCY RENAL DENERVATION MARKET,2020-2030(%)
- FIGURE 20.COMPARATIVE SHARE ANALYSIS OF ULTRASOUND RENAL DENERVATION MARKET,2020-2030(%)
- FIGURE 21.COMPARATIVE SHARE ANALYSIS OF MICRO-INFUSION RENAL DENERVATION MARKET,2020-2030(%)
- FIGURE 22.RENAL DENERVATION MARKET,BY END USER,2020(%)
- FIGURE 23.COMPARATIVE SHARE ANALYSIS OF HOSPITALS RENAL DENERVATION MARKET,2020-2030(%)
- FIGURE 24.COMPARATIVE SHARE ANALYSIS OF SPECIALTY CLINICS RENAL DENERVATION MARKET,2020-2030(%)
- FIGURE 25.COMPARATIVE SHARE ANALYSIS OF OTHERS RENAL DENERVATION MARKET,2020-2030(%)
- FIGURE 26.RENAL DENERVATION MARKET BY REGION,2020
- FIGURE 27.CHINA RENAL DENERVATION MARKET,2020-2030($THOUSAND)
- FIGURE 28.INDIA RENAL DENERVATION MARKET,2020-2030($THOUSAND)
- FIGURE 29.JAPAN RENAL DENERVATION MARKET,2020-2030($THOUSAND)
- FIGURE 30.AUSTRALIA RENAL DENERVATION MARKET,2020-2030($THOUSAND)
- FIGURE 31.REST OF ASIA-PACIFIC RENAL DENERVATION MARKET,2020-2030($THOUSAND)
- FIGURE 32.GERMANY RENAL DENERVATION MARKET,2020-2030($THOUSAND)
- FIGURE 33.FRANCE RENAL DENERVATION MARKET,2020-2030($THOUSAND)
- FIGURE 34.U.K. RENAL DENERVATION MARKET,2020-2030($THOUSAND)
- FIGURE 35.ITALY RENAL DENERVATION MARKET,2020-2030($THOUSAND)
- FIGURE 36.REST OF EUROPE RENAL DENERVATION MARKET,2020-2030($THOUSAND)
- FIGURE 37.LATIN AMERICA RENAL DENERVATION MARKET,2020-2030($THOUSAND)
- FIGURE 38.MIDDLE EAST RENAL DENERVATION MARKET,2020-2030($THOUSAND)
- FIGURE 39.AFRICA RENAL DENERVATION MARKET,2020-2030($THOUSAND)
- FIGURE 40.U.S. RENAL DENERVATION MARKET,2020-2030($THOUSAND)
- FIGURE 41.CANADA RENAL DENERVATION MARKET,2020-2030($THOUSAND)
- FIGURE 42.MEXICO RENAL DENERVATION MARKET,2020-2030($THOUSAND)
- FIGURE 43. TOP WINNING STRATEGIES, BY YEAR
- FIGURE 44. TOP WINNING STRATEGIES, BY DEVELOPMENT
- FIGURE 45. TOP WINNING STRATEGIES, BY COMPANY
- FIGURE 46.PRODUCT MAPPING OF TOP 10 PLAYERS
- FIGURE 47.COMPETITIVE DASHBOARD
- FIGURE 48.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
- FIGURE 49.ABLATIVE SOLUTIONS, INC.: NET SALES ,($THOUSAND)
- FIGURE 50.ABBOTT LABORATORIES.: NET SALES ,($THOUSAND)
- FIGURE 51.JOHNSON & JOHNSON.: NET SALES ,($THOUSAND)
- FIGURE 52.CARDIOSONIC LTD.: NET SALES ,($THOUSAND)
- FIGURE 53.BOSTON SCIENTIFIC CORPORATION.: NET SALES ,($THOUSAND)
- FIGURE 54.MEDTRONIC PLC.: NET SALES ,($THOUSAND)
- FIGURE 55.MERCATOR MEDSYSTEMS, INC.: NET SALES ,($THOUSAND)
- FIGURE 56.RECOR MEDICAL, INC.: NET SALES ,($THOUSAND)
- FIGURE 57.RENAL DYNAMICS LIMITED.: NET SALES ,($THOUSAND)
- FIGURE 58.TERUMO CORPORATION.: NET SALES ,($THOUSAND)
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook